Cargando…

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis: Erratum

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602982/ https://www.ncbi.nlm.nih.gov/pubmed/25802990 http://dx.doi.org/10.1097/01.md.0000464208.55673.5b

Ejemplares similares

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis
por: Liu, Po-Hong, et al.
Publicado: (2014)

Erratum: Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection
Publicado: (2017)

Effect of different surgical type of coronary artery bypass grafting on kidney injury: A propensity score analysis: Erratum
Publicado: (2017)

DNA Evidence Uncompromised by Active Oxygen
por: Castelló, Ana, et al.
Publicado: (2010)

Erratum to: Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis
por: Ohki, Takamasa, et al.
Publicado: (2016)

Erratum for Juvenile Hepatocellular Carcinoma in a Healthy Liver
por: Onishi, Sachiyo, et al.
Publicado: (2022)

Erratum to: Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
por: Ohki, Takamasa, et al.
Publicado: (2017)

Autoclavable Albumin-Based Cryogels with Uncompromising Properties
por: Duan, Kairui, et al.
Publicado: (2023)

Erratum to “Durable Objective Response to Sorafenib and Role of Sequential Treatment in Unresectable Hepatocellular Carcinoma”
Publicado: (2022)

Erratum to A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
Publicado: (2020)

Erratum to: Impact of implant surface type on breast cancer relapse after breast reconstruction: a propensity score-matched study
Publicado: (2023)

Erratum: Management of Hepatocellular Carcinoma: Current Status and Future Directions
Publicado: (2015)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System: Erratum
Publicado: (2015)

Erratum: Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
por: Fernández, Carmen Suárez, et al.
Publicado: (2015)

Erratum to the genetic association between type 2 diabetic and hepatocellular carcinomas
Publicado: (2022)

Erratum to atractylodin may induce ferroptosis of human hepatocellular carcinoma cells
Publicado: (2023)

Erratum: An Investigation into the efficacy of nursing curriculum on elderly health problems via Delphi's method
Publicado: (2019)

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study: Erratum
Publicado: (2023)

Erratum to: Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2013)

Erratum to: Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
por: Choi, Sung Hoon, et al.
Publicado: (2017)

Erratum to: Hepatocellular carcinoma with extrahepatic blood supply from right renal artery
por: Sohail, Amir Humza, et al.
Publicado: (2021)

Effect of CELSR3 on the Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells: Erratum
por: Xie, Zucheng, et al.
Publicado: (2022)

Diagnostic accuracy of serum dickkopf-1 protein in diagnosis hepatocellular carcinoma: an updated meta-analysis: Erratum
Publicado: (2020)

Erratum: SYNTAX Score in Patients with High Computed Tomography Coronary Calcium Score
Publicado: (2017)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma: Erratum
Publicado: (2015)

Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
por: Buta, Corina, et al.
Publicado: (2016)

Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma: Erratum
por: Liu, Zhikui, et al.
Publicado: (2023)

Erratum for Efficacy and Safety of the Japanese Herbal Medicine Daikenchuto (DKT) in Elderly Fecal Incontinence Patients: A Prospective Study
por: Shimazutsu, Kazufumi, et al.
Publicado: (2022)

Effects of preoperative oral management by dentists on postoperative outcomes following esophagectomy: Multilevel propensity score matching and weighting analyses using the Japanese inpatient database: Erratum
Publicado: (2019)

Erratum to “Changes of immune cells in patients with hepatocellular carcinoma treated by radiofrequency ablation and hepatectomy, a pilot study”
por: Yu, Zusheng, et al.
Publicado: (2022)

Meta-analysis of the efficacy of Ningmitai capsule on the treatment of chronic prostatitis in China: Erratum
Publicado: (2018)

FERTILITY PRESERVATION DURING THE COVID-19 PANDEMIC: MODIFIED BUT UNCOMPROMISED
por: Goldman, Kara N., et al.
Publicado: (2020)

Fertility Preservation During the COVID-19 Pandemic: Modified But Uncompromised
por: Trawick, Emma, et al.
Publicado: (2022)

Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline: Erratum
Publicado: (2017)

Erratum to: 24-h Efficacy of Glaucoma Treatment Options
por: Konstas, Anastasios G. P., et al.
Publicado: (2016)

Prognostic impact of the Controlling Nutritional Status score following curative nephrectomy for patients with renal cell carcinoma: Erratum
Publicado: (2019)

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results: Erratum
Publicado: (2017)

Erratum to “Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab”
Publicado: (2021)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rcc80pb9mvj1h8hpds2aphpp04